Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Citi
QuintilesIMS
Express Scripts
Colorcon
Fuji

Generated: March 19, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR FEBUXOSTAT

« Back to Dashboard

Clinical Trials for Febuxostat

Trial ID Title Status Sponsor Phase Summary
NCT00102440 Febuxostat Versus Allopurinol Control Trial in Subjects With Gout Completed Takeda Phase 3 The purpose of this study is to evaluate the safety and efficacy of febuxostat, once daily (QD), versus allopurinol in subjects with gout.
NCT00174915 Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects. Completed Takeda Phase 3 The purpose of this study is to compare febuxostat, allopurinol and placebo, once daily (QD), in subjects with gout.
NCT00174941 Long-Term Safety of Febuxostat in Subjects With Gout. Completed Takeda Phase 2 The purpose of this study is to evaluate the long-term safety of febuxostat, once daily (QD), in maintaining serum urate levels within clinically acceptable levels in subjects with gout.
NCT00174967 Dose-Response, Safety and Efficacy of Febuxostat in Subjects With Gout Completed Takeda Phase 2 The purpose of this study is to determine the efficacy of febuxostat, once daily (QD), in reducing serum urate levels in subjects with gout.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Febuxostat

Condition Name

Condition Name for Febuxostat
Intervention Trials
Gout 28
Hyperuricemia 13
Chronic Kidney Disease 3
Hypertension 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Febuxostat
Intervention Trials
Gout 22
Hyperuricemia 19
Kidney Diseases 8
Renal Insufficiency, Chronic 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Febuxostat

Trials by Country

Trials by Country for Febuxostat
Location Trials
United States 372
Japan 30
Canada 16
Australia 10
Poland 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Febuxostat
Location Trials
Texas 18
Florida 14
California 14
North Carolina 12
Kentucky 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Febuxostat

Clinical Trial Phase

Clinical Trial Phase for Febuxostat
Clinical Trial Phase Trials
Phase 4 16
Phase 3 13
Phase 2/Phase 3 1
[disabled in preview] 18
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Febuxostat
Clinical Trial Phase Trials
Completed 39
Not yet recruiting 9
Recruiting 8
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Febuxostat

Sponsor Name

Sponsor Name for Febuxostat
Sponsor Trials
Takeda 19
Ardea Biosciences, Inc. 6
AstraZeneca 3
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Febuxostat
Sponsor Trials
Industry 46
Other 38
NIH 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
Chinese Patent Office
McKesson
Merck
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.